Exosomes-based immunotherapy for cancer: Effective components in the naïve and engineered forms

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Cancer is a major challenge, driven by mutations causing uncontrolled cell proliferation and immune evasion.
• Tumor cells create a suppressive microenvironment, and exosomes play a role in intercellular communication.
• Exosomes derived from tumor or immune cells have therapeutic potential due to their characteristics.

Purpose of the Study:

• To review the therapeutic applications of naive and engineered exosomes in cancer treatment.
• To discuss methods for enhancing exosome therapeutic efficacy.
• To provide an update on recent advancements in exosome-based cancer therapy.

Main Methods:

• Review of existing literature on exosome-based cancer therapy.
• Analysis of exosome modification strategies, including cell of origin manipulation and drug encapsulation.
• Examination of therapeutic effects of exosomes from various cell types (e.g., tumor cells, NK cells, CTLs).

Main Results:

• Exosomes from tumor cells can induce anti-tumor responses via tumor peptides.
• Exosomes from immune cells (NK cells, CTLs) can induce tumor cell apoptosis.
• Naive exosomes have limited therapeutic function, but engineering significantly enhances their potential.

Conclusions:

• Engineered exosomes offer a promising strategy to overcome limitations of naive exosomes in cancer therapy.
• Exosome modification through cell of origin changes or drug encapsulation can improve anti-cancer efficacy.
• Further research into engineered exosomes is crucial for advancing cancer treatment.